Could Micron Hit $2 Trillion? The Price Target Just Tripled

Micron reported Q2 FY2026 revenue of $23.86B, up 196% year over year, with non-GAAP EPS of $12.20 and free cash flow of a quarterly record $6.9B. Q3 guidance calls for $33.5B ± $750M in revenue and roughly 81% gross margin, reinforcing the AI memory supercycle thesis as HBM remains sold out and supply tightness is expected beyond calendar 2026. UBS raised its price target to $1,625 and Barclays to $1,175, even as consensus remains well below the stock’s roughly $1.07T valuation.

Analysis

The market is no longer pricing Micron as a cyclical DRAM supplier; it is re-rating it as the toll booth for AI infrastructure. That matters because the real incremental winner is not just MU, but the broader high-bandwidth memory ecosystem: NVIDIA benefits from a more reliable supply path for its next-gen platforms, while the direct beneficiaries of constrained capacity are the few vendors with the cleanest process technology and the longest-dated customer commitments. Second-order, this should pressure smaller memory peers and weaker packaging/test vendors that lack the scale to secure multi-year allocation and will likely be forced to chase capacity at peak economics.

The key risk is that the stock is now trading on a narrative of structural scarcity just as the industry is announcing peak-cycle capex. That combination usually looks strongest 2-4 quarters before it becomes dangerous: lead times extend, customers rush inventory, then supply catches up faster than consensus expects. If hyperscaler AI spend merely normalizes from explosive growth to high growth, the multiple can compress even if earnings keep rising, because the market is discounting not only profits but permanence of scarcity.

The consensus may be underestimating how much of the upside is already embedded in expectations versus how little margin for execution error remains. A guide-to-guide beat is now required to sustain momentum; a merely good quarter could disappoint because investors are anchoring to hyperbolic sell-side targets and retail positioning. The contrarian read is that the bigger asymmetry may be in buying volatility, not outright stock: the setup supports further upside if the next print confirms scarcity, but a miss on HBM mix, pricing, or customer concentration would likely trigger a fast 15-25% reset in a name that has already absorbed a multi-bag rerating.

Key Decisions for Investors

• Maintain core long MU into the next earnings/event window, but size modestly: upside persists if Q3 revenue and margin guide are reaffirmed, yet the stock is now vulnerable to a sharp de-rating on any execution miss.
• Buy MU downside hedges via 3-6 month puts or put spreads financed against existing long exposure; the risk/reward is attractive because implied scarcity is high while cyclicality can reassert quickly if supply starts to normalize.
• Pair long MU / short a weaker memory or semi-capex laggard with exposure to the same AI buildout; the relative trade captures winner-take-most dynamics without taking full factor risk on semis.
• Use any post-earnings spike to trim 20-30% of tactical MU exposure and rotate into NVDA on pullbacks; MU has more operating leverage, but NVDA retains the cleaner platform multiple and less downside if the memory cycle peaks sooner than expected.
• For event-driven traders, consider a call spread instead of outright calls into the next print: the setup favors another leg higher, but the market has already repriced a lot of good news, so defined-risk upside is superior to paying full premium.